Cell Free DNA Sequencing: Fast & Precise Non-Invasive cfDNA Test
Clinical Overview & Diagnostic Indications
First of all, Non-Invasive cfDNA Test (cfDNA Sequencing) is the essential non-invasive molecular assay that isolates and sequences extracellular DNA fragments circulating in blood plasma. Essentially, using high-depth Next-Generation Sequencing (NGS), cfDNA profiling evaluates cell-free fetal DNA (cffDNA for NIPT), circulating tumor DNA (ctDNA for cancer), and donor-derived cell-free DNA (dd-cfDNA for organ transplant rejection) with 99.9% precision. Consequently, clinicians obtain crucial genetic insights without invasive procedures.
Furthermore, book your Non-Invasive cfDNA Test at Henotic Diagnostics for authoritative diagnostic accuracy. In addition, our accredited genomic laboratory operates 24/7 with specialized Streck cfDNA blood tube preservation kits.
📋 Your Cell Free DNA Sequencing at a Glance
| 🔍 Detail | 📋 Info |
|---|---|
| 🩺 Technology | High-Depth Next-Generation Sequencing (NGS cfDNA Fragment Assay) |
| 🩸 Sample Type | 10–20 mL Peripheral Blood in Cell-Free DNA Preservation Tubes |
| 💰 Price Range | ₹18,000 – ₹45,000 (All-inclusive diagnostic fee) |
| 📄 Report TAT | 5 to 10 Days (Includes clinical bioinformatic interpretation) |
| 🕐 Availability | 24/7 Operations (Complimentary Streck tube kit delivery) |
| 👩⚕️ Specialist | Dr. Pratibha Patil — Chief Consultant Radiologist |
| 🍽️ Fasting | No Fasting Required (Normal diet maintained) |
| 💳 Insurance | Reimbursement Documentation Support provided |
| 🏅 Accreditation | NABL Accredited · ISO Certified · CAP Compliant |
Cell Free DNA Sequencing Quality Standards & Certifications
Cell Free DNA Sequencing: Overview
To begin with, Non-Invasive cfDNA Test is a revolutionary non-invasive diagnostic technique that analyzes fragments of DNA shed into blood plasma from apoptosis or necrosis of various tissues. At the same time, experts at Henotic Diagnostics deploy ultra-deep Next-Generation Sequencing to decode cell-free nucleic acids across maternal, oncology, and organ transplant applications.
Furthermore, comfortable reception lounge providing supportive patient registration for non-invasive cfDNA blood testing
What Does Cell Free DNA Sequencing Evaluate?
Specifically, Non-Invasive cfDNA Test measures short double-stranded DNA fragments (typically 120-180 base pairs) floating in blood plasma. Consequently, bioinformatic algorithms differentiate cell-free fetal DNA (cffDNA for Trisomy 21, 18, 13 NIPT screening), circulating tumor DNA (ctDNA for somatic cancer driver mutations), and donor-derived cell-free DNA (dd-cfDNA for allograft organ rejection). Furthermore, fragmentomics analysis detects nucleosomal patterns. As a result, physicians obtain actionable diagnostic data safely. In fact, to review non-invasive prenatal cfDNA guidelines, consult the NIH NHGRI Noninvasive Prenatal Testing Fact Sheet.
Furthermore, high-depth cfDNA profiling providing comprehensive reports empower physicians with non-invasive prenatal, oncology, and transplant insights.
What is Cell Free DNA Sequencing?
In general, dying cells release small fragments of nuclear and mitochondrial DNA into extracellular body fluids. Essentially, Non-Invasive cfDNA Test uses high-throughput Next-Generation Sequencing (NGS) to isolate, amplify, and sequence these minute circulating fragments from blood plasma. Therefore, advanced bioinformatic error-suppression methods quantify rare variants and fragment lengths down to 0.1% frequency. Additionally, to read about clinical cfDNA advancements, examine the Nature Reviews Clinical Oncology journal.
Additionally, high-throughput NGS sequencers isolate and sequence plasma cell-free DNA with 99.9% analytical accuracy
What Does Cell Free DNA Sequencing Check?
Overall, clinical Non-Invasive cfDNA Test spans three core diagnostic domains:
Key Clinical Applications Evaluated
In addition, bioinformatic software maps cell-free DNA fragment size ratios, fetal fraction percentages, and mutant allele frequencies
When Is Cell Free DNA Sequencing Recommended?
For example, obstetricians recommend Non-Invasive cfDNA Test (NIPT) starting at week 10 of pregnancy for non-invasive fetal trisomy risk screening. In particular, oncologists order cfDNA liquid biopsy when tumor tissue is inaccessible or to track therapy resistance in real time. Moreover, transplant surgeons utilize donor-derived cfDNA to monitor allograft health without invasive organ biopsies. In addition, to review ACMG clinical genetics guidelines, examine the ACMG Medical Genetics Guidelines.
Moreover, expert geneticists interpret cell-free DNA results to provide non-invasive clinical recommendations
Clinical Superiority: Non-Invasive cfDNA Plasma Assay vs. Invasive Biopsies
Ideally, clinicians choose Non-Invasive cfDNA Test because it replaces risky invasive procedures (such as amniocentesis, core needle tissue biopsy, or organ transplant biopsy) with a standard peripheral blood draw. In addition, cfDNA sequencing provides rapid results with zero procedure-related complication risks. Indeed, to review global diagnostic health standards, consult the WHO Medical Diagnostics Fact Sheet.
Cell Free DNA Sequencing Cost Guide
| Clinical cfDNA Service | Approximate Cost (₹) |
|---|---|
| Prenatal Cell-Free Fetal DNA Screen (NIPT Basic) | First, prenatal cfDNA NIPT pricing is ₹18,000 – ₹24,000. |
| Oncology Circulating Tumor DNA Liquid Biopsy (ctDNA) | Second, oncology ctDNA liquid biopsy costs ₹35,000 – ₹45,000. |
| Donor-Derived Cell-Free DNA Transplant Monitor (dd-cfDNA) | In addition, transplant dd-cfDNA costs ₹28,000 – ₹38,000. |
| Specialized Streck cfDNA Blood Collection Tube Kit | Finally, Streck blood tube kit delivery is complimentary. |
Comparison: cfDNA Blood Assay vs. Invasive Biopsy Procedures
On one hand, invasive tissue and fetal biopsies carry physical discomfort and procedural risk, whereas Non-Invasive cfDNA Test offers equal diagnostic accuracy through a simple blood draw. Consequently, cfDNA screening has transformed modern clinical workflows. In fact, review the PubMed Clinical Cell-Free DNA Review.
| Feature | Cell Free DNA Sequencing (cfDNA) | Invasive Diagnostic Biopsy |
|---|---|---|
| Procedural Safety | First, 100% non-invasive blood collection. | However, carries miscarriage / surgical risk. |
| Turnaround Time | Second, fast report within 5 to 10 days. | In contrast, 14 to 21 days including cell culture. |
| Repeat Testing Ease | In addition, easily repeated serially over time. | Meanwhile, difficult and painful to repeat. |
| Clinical Accuracy | Finally, >99% accuracy for trisomies & ctDNA. | Likewise, high accuracy but invasive. |
Frequently Asked Questions
What is Cell Free DNA (cfDNA) Sequencing? ▼
First, Non-Invasive cfDNA Test is a non-invasive blood assay that isolates and sequences extracellular DNA fragments circulating freely in blood plasma.
What clinical applications use Cell Free DNA Sequencing? ▼
In addition, cfDNA sequencing is widely used for non-invasive prenatal screening (NIPT), cancer liquid biopsy (ctDNA), and donor-derived transplant rejection monitoring (dd-cfDNA).
What blood sample tube is required for cfDNA Sequencing? ▼
Generally, 10-20 mL of peripheral blood collected in specialized cell-free DNA blood preservation tubes (Streck cfDNA tubes) is required.
Do I need to fast before Cell Free DNA Sequencing? ▼
Because cfDNA sequencing evaluates circulating cell-free nucleic acids, fasting is unnecessary.
How long until I receive diagnostic cfDNA results? ▼
Fortunately, detailed clinical bioinformatic cfDNA reports are delivered within 5 to 10 business days.
What is the cost of Cell Free DNA Sequencing? ▼
Overall, high-precision Non-Invasive cfDNA Test ranges from ₹18,000 to ₹45,000 depending on the clinical panel and sequencing depth.
Quick Appointment Booking
Schedule your Cell Free DNA Sequencing with accredited genomic experts.
Call: 088793 27184 WhatsApp BookingTest Summary
Reporting Clinical Genomic Specialist
Dr. Pratibha Patil
Chief Consultant Radiologist & Clinical Diagnostics Specialist
MBBS, MD (Radiodiagnosis) · 15+ Years Clinical Experience
Furthermore, your Cell Free DNA Sequencing data is evaluated by accredited molecular geneticists and bioinformaticians. Consequently, comprehensive reports empower physicians with non-invasive prenatal, oncology, and transplant insights.
Our Accreditations & Quality Standards
Certified excellence ensuring cfDNA sequencing depth, bioinformatic fragment calling accuracy, and patient privacy.
What Our Patients Say
Real feedback from patients who completed Cell Free DNA Sequencing with us.
“Cell Free DNA Sequencing provided complete non-invasive prenatal peace of mind during week 10. Furthermore, home blood collection was prompt and effortless!”
– Pooja R.
Verified Patient Review“Extremely clear ctDNA liquid biopsy report identifying EGFR targeted therapy options. In addition, report delivery took only 6 business days.”
– Deepak M.
Verified Patient Review“Premier NABL accredited cell-free genomic center. Henotic Diagnostics is our trusted referral laboratory for advanced cfDNA diagnostics.”
– Dr. Kavita S.
Verified Clinical Geneticist ReviewRelevant Diagnostic Genomic & Molecular Services
Corporate Booking Office & Location
If you require Cell Free DNA Sequencing for prenatal screening, ctDNA liquid biopsy, or organ transplant monitoring, do not delay. Call to schedule your sample collection.
Henotic Diagnostics
Second floor, Millennium Empire, Business Park, Plot No 47, D Mart Rd, Sector 15, Kharghar, Navi Mumbai, Panvel, Maharashtra 410210
Phone: 088793 27184 | Hours: Open 24 Hours